SAYJ Global Partners

Total investments

2

Average round size

2M

Portfolio companies

2

Rounds per year

0.40

Lead investments

1

Stages of investment
SeedEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologyHealth CareHospitalGeneticsMedical

Summary

In 2017 was created SAYJ Global Partners, which is appeared as Corporate Investor.

The usual cause for the fund is to invest in rounds with 4-5 partakers. The meaningful sponsors for the fund in investment in the same round are Vital Capital, Stanford University, Prolog Ventures. In the next rounds fund is usually obtained by Keiretsu Forum.

The common things for fund are deals in the range of 1 - 5 millions dollars. The fund is generally included in less than 2 deals every year. The top activity for fund was in 2018.

The fund was created by Judith Pacult Iglehart.

Among the most popular portfolio startups of the fund, we may highlight Toma Biosciences. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Health Care, Genetics.

Show more

Investments analytics

Analytics

Total investments
2
Lead investments
1
Rounds per year
0.40
Investments by industry
  • Health Care (2)
  • Medical (1)
  • Hospital (1)
  • Genetics (1)
  • Biotechnology (1)
Investments by region
  • United States (2)
Peak activity year
2018

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
8
Group Appearance index
0.50

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Toma Biosciences 21 Jul 2018 Biotechnology, Health Care, Genetics Late Stage Venture 3M United States, California, Foster City
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.